Find a Doctor

Jorg J. Vehreschild

University Hospital Of Cologne

Bio


Jorg Vehreschild is in Frankfurt Am Main, Germany. They have been an author on 130 peer reviewed articles and participated in 3 clinical trials in the past 15 years.

Contact

Frankfurt Am Main, HE, DE

Latest Research


Latest Advance
Study
  • Condition: Clostridioides Difficile Infections (CDI) in Patients with Acute Myeloid Leukemia (AML) Undergoing Intensive Induction Chemotherapy
  • Journal: Annals of hematology
  • Treatment Used: Carbapenems and Glycopeptides
  • Number of Patients: 415
  • Published —
This study analyzed the incidence of Clostridioides difficile infections (CDI) in patients with acute myeloid leukemia (AML) undergoing intensive induction chemotherapy.
Latest Advance
Study
  • Condition: Mucormycosis
  • Journal: The Journal of antimicrobial chemotherapy
  • Treatment Used: Posaconazole New Formulation (MoveOn)
  • Number of Patients: 45
  • Published —
This study tested the safety and efficacy of using the MoveOn formulation to treat patients with invasive mucormycosis.
Latest Advance
Study
  • Condition: HIV-1
  • Journal: Nature medicine
  • Treatment Used: HIV-1 Broadly Neutralizing Antibodies
  • Number of Patients: 7
  • Published —
This study evaluates the efficacy of an alternative to the standard HIV antiretroviral agents with a combination therapy involving anti-HIV-1 broadly neutralizing antibodies.

Contact

Frankfurt Am Main, HE, DE

Insurance

Contact them to find out if they accept your insurance plan.